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Abstract 
Human skin is a region of high metabolic activity where secretion of a rich variety of biomarkers occurs 
throughout the stratum corneum. The skin is a constant source of volatile organic compounds (VOCs) derived 
from the skin glands and the resident microbiota. Skin VOCs contain the footprints of cellular activities and 
thus offer a unique insight into the intricate processes of cutaneous physiology. This review examines the 
growing body of research on skin VOC markers as they relate to skin physiology, whereby variations in skin 
intrinsic and microbial metabolic processes give rise to unique volatile profiles. Emerging evidence for volatile 
biomarkers linked to skin perturbations and skin cancer are examined. Microbial-derived VOCs are also 
investigated as prospective diagnostic markers, and their potential to shape the composition and diversity of the 
local skin microbiota, and consequently cutaneous health, is considered. Finally, a brief outlook on emerging 
analytical challenges and opportunities in the development of non-invasive tools for skin VOC-based research 
and diagnostics is presented.  
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1. Introduction 
The skin is the first line of defense between the human body and its external environment, preventing loss 
of moisture and entry of pathogenic organisms. It is a region of high metabolic activity where secretion of a rich 
variety of biochemical markers occurs throughout the stratum corneum (SC), including lipids, peptides, 
proteins, cytokines, nucleic acids and volatile organic compounds (VOCs). It is also an ecosystem, home to 
diverse microbial communities that influence human health and disease, and which secrete their own 
metabolites including toxins, antibiotics and VOCs. Local skin biochemistry offers a valuable insight into health 
as it can reflect various pathologies including localised diseases like atopic dermatitis, psoriasis and cancer [1], 
and even systemic conditions such as diabetes and cardiovascular disease [2].  
Skin volatile emissions are attracting considerable scientific and clinical interest in recent years as they 
contain the footprints of cellular activities and can thus reflect the metabolic condition of an individual, offering 
a non-invasive route to probe the body’s biochemistry [3]. Skin VOCs are derived from apocrine, eccrine and 
sebaceous gland secretions, and their interactions with microorganisms on the surface. Different regions of skin 
emit specific VOCs generating a complex mixture of compounds often referred to as human odour [4] 
comprising a diverse group of carbon-based molecules that are volatile at ambient temperatures. A compendium 
of VOCs from the human body was recently published, outlining a total of 1840 compounds from skin, breath, 
blood, urine, feces, saliva and milk. Skin secretions were assigned 532 compounds [5] and featured a variety of 
compound classes including hydrocarbons, carboxylic acids, aldehydes, alcohols, esters, ketones and amines. 
Skin volatiles are generating significant interest in numerous fields, from cosmetics (e.g. in the design of 
fragranced products such as perfumes and deodorants) [6] [7], to diagnostics [8], forensics [9], safety and 
security applications (e.g. search and rescue) [10], monitoring psychological stress [11], and ecology of blood-
sucking insect vectors of human disease [12]. Recent research has highlighted the link between skin volatiles 
and the potential passage of compounds from blood vessels [13], dietary influences [13-[15] and age-related 
metabolic activity [16]. Environmental factors and personal habits can also influence skin volatile composition, 
including level of physical activity, personal hygiene, and cosmetic or fragrance usage [9]. Monitoring skin 
volatiles offers a non-invasive route towards probing pathophysiological status and monitoring therapy, and 
research in this area to date has primarily focused on internal or systemic disease states for which consistent 
data has emerged on clinically important skin volatiles, including diabetes [17], hepatic disease [18] and malaria 
[19].  
Skin volatile profiles reflect metabolites of the dermal and epidermal cellular layers and the compounds 
carried to and from the skin via the blood stream. They also reflect the volatile metabolites derived from the 
skin flora and the environmental volatiles on the surface of skin. In cases of perturbation to the skin (e.g. barrier 
disruption, tissue damage or cancer) the volatile profiles may be changed by alterations in cellular metabolism. 
Volatile profiles may also be altered by the loss of normal skin cellular layers and their metabolites, or by 
metabolites associated with the processes of infection and healing. Consequently, skin VOCs can provide a 
unique insight into the intricate processes of cutaneous health and disease. There is a growing body of research 
highlighting the value of this approach to reveal important biochemical information about the skin, wherein 
variations in skin intrinsic metabolic processes and commensal microbial populations generate unique volatile 
profiles. Characteristic volatile profiles have been reported for chronic wounds [20], melanoma [21], 
compressed tissue [22], and skin barrier impairment [23] thus volatile analysis can reveal important information 
about the health of the skin itself. This approach could be invaluable for monitoring barrier function, tissue 
damage or skin/wound infection and healing, where a non-invasive approach could reduce reliance on surgical 
excisions. Furthermore, it could enrich understanding of underlying skin metabolism and physiology in a non-
destructive manner with applicability to cell culture and human research alike. This review will provide an 
overview of emerging research on volatiles as they relate to skin physiology, where the rich biochemistry of 
skin volatile secretions can be exploited to develop non-invasive approaches to measure skin properties, monitor 
skin disorders, evaluate efficacy of treatment, or detect disease or infection at an early stage. 
 
2. Discussion 
2.1 Sampling and analysis of skin volatile emissions  
Studying skin VOCs requires a high degree of analytical sensitivity due to the low concentrations (low to 
sub-ppb) emanating from skin. This has led to a reliance on mass spectrometric methods for their analysis. A 
detailed overview of analytical techniques for VOCs from the human body is provided in a recent review [24]. 
Briefly, techniques for their analysis include gas chromatography coupled with mass spectrometry (GC-MS) 
and direct MS methods such as selected ion flow tube mass spectrometry (SIFT-MS) [13], proton transfer 
reaction mass spectrometry (PTR-MS) [25], membrane inlet mass spectrometry (MIMS) [26] and secondary 
electrospray ionization mass spectrometry (SESI-MS) [27]. Gas chromatography has been coupled with ion 
mobility spectrometry (IMS) for near real-time characterization of skin volatiles [28] [29], however, parallel 
GC-MS analysis is vital to reliable compound identification as IMS does not have a commercially available 
substance library. Electronic noses (e-nose) have also been employed for skin VOC detection and recognition 
in armpit odours [30] and melanoma [21]. An e-nose comprises an array of chemical sensors (e.g. 
electrochemical, gravimetric or optical sensors) for detection and classification of VOCs. It offers a 
miniaturized, sensitive and rapid approach to the analysis of volatile mixtures without the need for their 
separation into individual components but provides limited identification. E-noses are prone to signal drift and 
reduced sensitivity in the presence of water vapour or high concentrations of a single analyte [31].  
GC-MS is the gold standard technique for investigation of trace level VOCs, with advanced identification 
mechanisms and a capacity to analyse hundreds of species simultaneously. Headspace solid-phase 
microextraction (SPME) with GC-MS has emerged as the method of choice in skin volatile research, owing to 
the sensitivity and identification capabilities of MS coupled with the ease of performing headspace (HS) 
sampling with SPME [16] [23] [32] [33] [34]. The determination of skin volatiles often requires a pre-
concentration step to enrich the target compounds to fit within the range of detection of the analytical system. 
HS-SPME pre-concentration is sensitive, non-invasive, solvent free and easily performed in vivo, reducing 
reliance on more labour intensive methods like bag sampling. It enables trapping of volatiles on adsorbent 
coated fibres followed by direct thermal desorption in a GC injector, and can be used for direct sampling of skin 
VOCs, or to extract a sample collected through an intermediary (e.g. cotton or gauze pads) in contact with the 
skin. A review of techniques for sampling skin VOCs is provided by Dormont et al. [35]. Briefly, these methods 
include solvent extraction [16] and VOC collection onto adsorbents in headspace or contact mode (e.g. glass 
beads, cotton gauze, polydimethylsiloxane membranes) [12], [36], [37]. More recently, polydimethylsiloxane 
tubing has been employed as a wearable passive sampler looped around the wrist or ankle [38]. Volatiles can 
be recovered from these phases for subsequent analysis via thermal desorption, solvent extraction, or collection 
onto an adsorbent trap (e.g. porous polymer adsorbent) using an airflow process. Headspace sampling is 
preferable, since contact sampling can introduce interferents (e.g. dust, lipids, non-volatiles) to the sample, 
which can contaminate the GC injector and column [37]. Numerous studies have included some degree of 
control over skin pre-treatment prior to sample collection to reduce environmental contributions. Participants 
are generally requested to avoid using cosmetics on the day of sampling, and to wash the skin site with water, 
or with fragrance-free soap prior to sampling [9], [39]. However, the influence of cosmetics is generally still an 
issue, with some compounds persisting in excess of 2 weeks in the skin [12]. Other studies have included a 
degree of control over dietary factors [40] or introduced an exercise component to generate sweat prior to 
sampling [33].  
 
 
2.2 Endogenous skin volatile emissions in vivo and in vitro  
Over 500 volatiles have been reported isolated from skin secretions [5]. Studies employing headspace 
sampling of skin typically recover between 20-90 VOCs that are airborne at normal body temperature [35] with 
recovered compounds spanning a variety of chemical classes including hydrocarbons, aldehydes, alcohols, 
carboxylic acids, esters, ketones and amines. Skin volatiles predominantly derive from gland secretions and the 
metabolism of the skin microbiota. The skin glands are located in the dermis and terminate in secretory ducts 
that open on the skin’s surface. Gland distribution at the skin surface varies across the body and is partially 
reflected in the regional diversity of skin volatiles. Apocrine glands secrete sweat; a turbid fluid containing 
water, lipids, proteins, and odour precursors [41]. They are localized in a few regions of skin and contribute 
greatly to VOC emissions produced from the axillary regions which also harbor a diversity of microbial flora. 
Axillary volatiles primarily contain C6-11 carboxylic acids and alkanes [35]. The sebaceous glands secrete sebum 
which has the function of lubricating the skin. Sebum is composed of triglycerides, wax esters, squalene and 
free fatty acids. Comparison of volatiles in sites of differing sebaceous gland density revealed a considerable 
number of overlapping compounds, and some notable differences relating to the site of emanation [16]. Eccrine 
glands are distributed across the skin and have their functions in excretion and thermoregulation by secreting 
water and electrolytes. They also play a role in maintaining skin homeostasis by secreting moisturizing factors 
such as lactate, urea, sodium and potassium to maintain skin hydration [42]. Eccrine secretions originate in the 
extracellular interstitial fluid, and therefore reflect blood plasma chemistry [43]. They are distributed across the 
body and contribute to VOC mixtures from numerous regions on the skin. 
Some of the most frequently reported volatile compounds recovered from skin include nonanal, decanal, 
6-methyl-5-hepten-2-one and 6-10-dimethyl-5,9-undecadien-2-one (geranyl acetone), followed by hexanal, 
octanal, benzyl alcohol, (E)-2-nonenal, undecanal and hexadecane. [35] Volatile profiles from feet are often 
dominated by short chain fatty acids (SCFAs) whereas hand and forearm volatiles tend to exhibit a greater 
distribution of aldehydes and ketones. [16], [44], [45], [46] Several VOCs have been proposed as markers of 
increasing age including (E)-2-nonenal [47], nonanal, dimethylsulfone and benzothiazole [16]. Numerous 
gender marker compounds have also been proposed, (including pentadecanoic acid, hexadecenoic acid, 
heptadecanoic acid, nonadecane and docosane) which permitted discrimination between the sexes in a study on 
axillary emanations collected from 89 men and 108 women using PDMS-coated stir bars [48]. Variations 
between individuals’ volatiles due to microbial influences have also been reported [35], [44]. 
A library of endogenous VOCs has been proposed based on volatile profiling of human cell lines [49]. 
Analysis of VOCs in human primary cells, cell lines and cultures of microorganisms is expected to provide 
invaluable insights into the biochemistry of volatile compounds observed in humans. Complementary studies 
on skin VOCs from different sources (tissue and culture studies) will assist in validating the origin of candidate 
compounds and their potential association with health or disease. HS-SPME sampling offers a non-invasive 
method of biochemical interrogation that is repeatable and easily performed on cell culture, tissue and human 
participants. Our group have recently demonstrated an HS-SPME method for characterization of volatiles in 
vitro and in vivo [50]. A total of 16 compounds were reliably identified from HS-SPME GC-MS analysis of 3D 
human skin equivalents (HSEs). A similar variety of compound classes to that present in normal skin was 
observed (with the addition of terpenic compounds camphene, camphor and isoborneol), however the individual 
compounds and their relative distribution varied substantially between HSEs and human skin. Esters comprised 
the largest portion of the HSE volatile profile, followed by acids, aldehydes and terpenes. There were 3 common 
compounds in HSEs and participants (octanal, nonanal, and 2-ethyl-1-hexanol) and several other VOCs present 
in HSE samples which were reported elsewhere in human participants (nonanol, camphor and n-hexadecanoic 
acid). A number of compounds identified were attributed to exogenous sources, including ethylbenzene, styrene 
and 2-ethyl-1-hexanol. Volatile profiles in monolayer (2D) and 3D matrix immobilized cultures of human 
dermal fibroblasts were compared using HS-SPME GC-MS by Acevedo et al. 6 compounds (cyclohexanol, 
styrene, benzaldehyde, ethylhexanol, acetophenone and 1,3-di-tert-butylbenzene) were identified, however, all 
6 compounds were also present in the medium control samples and therefore unlikely to be endogenous in origin 
[51]. Numerous compounds identified in cellular VOC studies appear not to be from cellular metabolism but 
are instead derived from exogenous sources such as the growth medium or environmental contaminants [52]. 
The detection of metabolic changes via skin VOCs will be enabled by a combined knowledge of the cellular 
source and the fundamental biochemical process, which demands careful characterization of VOCs in vitro and 
in vivo.  
  
2.2.1 Skin perturbations alter volatile emissions  
Skin volatiles reflect metabolites of the dermal and epidermal cellular layers and the compounds carried to 
and from the skin via the blood stream. In cases of skin perturbation, the volatile profiles may be changed by 
alterations in cellular metabolism. Prolonged compression can limit the availability of oxygen in a region of 
tissue under mechanical load [53]. Early detection of compression tissue damage via volatile markers from the 
skin was proposed by Dini et al. [22]. They employed a cotton patch sampling approach with subsequent 
extraction by SPME and analysis by GC-MS and electronic nose. Compressed and non-compressed regions of 
skin were sampled in 9 healthy participants and 9 hospitalized intensive care patients. Differences were observed 
in the chromatographic pattern of volatiles for compressed and non-compressed tissue (Table 1). However, 
differing volatile emissions were observed for hospitalized patients and healthy participants, irrespective of the 
condition of the tissue. This was attributed to differences in the medication and environment of the 2 groups. 
Further research is needed to understand these environmental effects (hospital vs other settings) and to elucidate 
volatile markers representing the early onset of pressure ulcers. This could inform development of a portable 
diagnostic approach, such as an electronic nose, with sensing materials specific to those markers permitting 
early detection of tissue damage prior to pressure ulcer occurrence.  
Skin perturbation via acute disruption to the skin barrier induces obvious epidermal hyperplasia and 
inflammation, and can result in accelerated lipid synthesis, increased epidermal DNA synthesis and cytokine 
production [54]. Our research group have demonstrated that skin barrier disruption can impact the volatile 
emissions from skin [23]. The volatile profile of healthy skin was investigated before and after acute barrier 
disruption through tape stripping of the stratum corneum. Tape stripping is a simple, robust method used in skin 
physiology research and as an in vivo model for skin diseases characterized by skin barrier weakening, such as 
atopic dermatitis. Discriminating volatile profiles were observed for all 7 participants before and after acute 
barrier disruption. Volatile emissions revealed the protective hydro-lipid film that functions within the skin 
barrier was impacted, with compounds from sebaceous components and their oxidation products (e.g. squalene, 
squalene, octanal, nonanal) showing substantial changes after barrier disruption (Table 1). Glycine up-
regulation was also observed and may indicate an impact on the skin’s natural moisturizing factor. This 
approach could enrich understanding of skin barrier function and treatment efficacy, which are key to improving 
outcomes for chronic conditions like atopic dermatitis and psoriasis. The observed up-regulation of exogenous 
compounds (linalool and phenethyl alcohol) in the study underlines the persistence of exogenous compounds 
on the skin and suggests the skin volatilome might provide a useful source of information regarding an 
individual’s environment and exposures. Volatile screening offers the potential to detect changes in the skin 
that are undetectable in the traditional palpable and visual assessment, it could reduce reliance on surgical 
excisions and may provide opportunities for early detection of tissue damage, barrier impairment, or irritant 
reactions for application in areas such as clinical diagnostics, physiology research and cosmetic and skincare 
testing.  
 
2.2.1 Emerging volatile markers for skin cancer  
There have been a number of anecdotal reports of canine olfactory detection of skin cancers (melanoma 
and more recently basal cell carcinoma) which has motivated the training of dogs as a diagnostic tool [55], [56], 
[57]. To date this research has primarily focused on melanoma, which is represented in a low percentage of skin 
cancer cases (~5%) but is classified as the deadliest form of skin cancer, accounting for up to 75% of all skin 
cancer deaths [58]. Dogs trained to sniff patients were correct in identifying 75-86% of melanomas hidden 
beneath bandages [59]. This suggests the emission of unique volatile metabolic products of melanoma 
pathophysiology that differ from that of healthy skin or moles. Cancer cells have altered metabolisms, which 
are expected to produce different profiles of metabolites and this has motivated a growing interest in developing 
a non-invasive diagnostic approach around skin volatiles [21],[52], [60]. Currently the gold standard diagnostic 
approach for melanoma involves excisional biopsy and histological examination of suspicious lesions. There is 
a demand for more objective and less-invasive examination methods to support clinicians in determining when 
to perform a biopsy [61]. Volatile screening could permit early detection of melanoma in a non-invasive manner 
which may increase the chance of successful treatment.  
Discovery of differences in volatiles between melanoma and normal skin is best accomplished using GC-
MS, however, translation of such an approach into a clinical setting requires user-friendly portable analytical 
technology (e.g. e-nose). Studies employing gas sensor arrays (comprising 7 quartz crystal microbalance (QCM) 
chemical sensors, each coated with a different metalloporphyrin) and GC-MS have reported that melanoma-
related volatiles differed from those of normal skin, however, compound identities were not reported for 
volatiles that could discriminate between melanoma and normal skin [21]. PLS-DA modelling of sensor array 
data collected from 40 participants (including 9 melanoma) revealed a degree of separation between naevi and 
melanoma, with correct prediction of melanoma reported for 70% of cases. GC-MS characterization of volatile 
emissions in 2 of these participants (comparing naevi, normal skin and melanoma) revealed subtle differences 
in the chromatogram relating to skin cancer, with 1 compound identity suggested (propanal). Any other relevant 
compounds could not be elucidated due to low relative abundances [21].  
More recent research is shedding light on the composition of volatile emissions from melanoma, naevi and 
normal skin. HS-SPME GC-MS characterization of volatiles in punch biopsy melanoma and normal skin 
samples revealed differences in the volatile signatures, with up-regulation of lauric acid and palmitic acid 
reported for melanoma samples [62]. However, numerous other compounds reported from GC-MS analyses of 
melanoma volatiles do not appear to be from cell metabolism. Compounds such as methoxy-phenyl oxime, 
butylated hydroxytoluene [63], isopropyl palmitate, propylene glycol, 2-ethyl-1-hexanol and styrene [60] are 
all likely derived from exogenous sources. Control sampling and examination of corresponding mass spectra 
should permit elimination of compounds arising from environmental or instrumental artifacts (including column 
bleed SPME fibre volatiles, background air and cosmetics). After eliminating such contaminants from their 
chromatographic data, Kwak et al. discovered differences in volatile sulfur compounds in the headspace of 
cultured melanoma cells and normal melanocyte cells using SPME with GC-MS. They investigated volatile 
emissions from three types of primary melanoma cells (radial growth phase, vertical growth phase and 
metastatic melanoma cells) as well as normal neonatal foreskin melanocytes. Melanoma cells grown in culture 
produced dimethyl disulfide and dimethyl trisulfide, two volatiles which were not present in those emitted by 
normal melanocyte cultures [52]. Furthermore, dimethylsulfone was seen in greater amounts in metastatic 
melanoma cells compared to normal cells, and metabolic differences between these two cell types in the 
processing of benzaldehyde was proposed. Detection of melanoma biomarker dimethyl disulfide using cavity 
ringdown spectroscopy at 266 nm has been investigated as an alternative diagnostic approach, with potential 
for sub-ppb detection limits reported [64]. Application of a gas sensor array comprising single walled carbon 
nanotubes functionalized with single stranded DNA to cell culture supernatants demonstrated distinguishing 
differences in volatiles from normal and melanoma cells, and from different types of melanoma cells. [52] Both 
canine olfactory recognition of melanoma and emerging evidence of differences in volatiles from melanoma 
and normal skin (cells and biopsies) offer promise to advancing the early detection of melanoma using non-
invasive analytical techniques. Careful elucidation of endogenous volatile biomarkers with consideration of 
environmental contaminants will inform development of selective detection strategies suitable for translation to 
clinical applications.   
 
2.3 Cutaneous microflora and microbial volatile emissions  
Human skin is colonized by a large diversity of microorganisms collectively known as the skin microbiota. 
The skin microbiota is made up of complex and dynamic communities of microbes including bacteria, viruses 
and fungi. Microbial profiling via 16S rRNA sequencing has revealed the presence of highly diverse 
communities across distinct topographical skin sties. These communities are generally dominated by bacteria 
belonging to 3 main phyla (Actinobacteria, Bacteriodes and Firmicutes) [65]. There is growing recognition 
around the cutaneous microflora as an important component of skin health, as well as many disease processes 
[66]. Microbial etiological agents are associated with various skin disorders, including Staphylococcus aureus, 
Staphylococcus epidermidis and Propionibacterium acnes [67][68] and dysbiosis in the skin microbiota has 
been associated with cutaneous inflammatory disorders including psoriasis, atopic dermatitis (AD) and rosacea 
[65] [69][70]. However, the majority of bacteria resident on the skin are non-pathogenic commensals that can 
be beneficial for their host in numerous ways, such as through immune system regulation [71] or elimination of 
competing pathogens through production of toxic compounds like bacteriocins or antibiotics [69] [72]. As part 
of their normal metabolism, microorganisms produce VOCs, and microbial volatile organic compounds 
(mVOCs) comprise a wide variety of compound types including fatty acids and their derivatives (e.g. 
hydrocarbons, alcohols, ketones), nitrogen- and sulfur-containing compounds, terpenoids and aromatic 
compounds [73]. The composition of volatiles produced by a microbial community is dependent on the diversity 
and types of species present and the environmental conditions including the availability of carbon energy 
sources, and conditions like pH and temperature [74]. HS-SPME GC-MS screening of VOC profiles from 
human skin microbiota representatives growing under diverse conditions in vitro revealed differential 
production of volatiles depending on bacterial strain and growth conditions (incubation temperature and media 
composition) [75]. The majority of volatiles observed from bacterial cultures under investigation were alkenes, 
alcohols, ketones and aldehydes (products of fatty acid biosynthesis). Volatiles produced by Pseudomonas 
aeruginosa were dominated by 1-undecene and an increase in the prevalence of long chain methyl ketones (e.g. 
2-undecanone) was observed when incubation temperature was raised from 30 to 37 °C. The 3 strains of 
Staphylococcus epidermidis investigated all produced significant amounts of long chain methyl ketones with 
fewer alcohols, aldehydes and alkenes present. However, differences in the breakdown of VOCs between strains 
were apparent, with 3-methylbutanal production observed in only 1 of 3 strains. Among the other bacterial 
strains investigated, R erythopolis produced no identifiable VOCs, and low levels of VOCs were recovered from 
B. epidermidis and C. xerosis including 2-butanone and 2-acetylthiazle [75].  
In addition to producing VOCs as part of their normal metabolism, the skin microbiota also produces VOCs 
by metabolizing secretions from our skin glands, which can have a major impact on the composition of our 
VOC profile (i.e. our body odour). The topographical diversity in the microbiota and the distribution of glands 
in different skin sites results in variations in the volatile profile with emission site [52]. Corynebacterium species 
degrade precursor compounds found in odourless apocrine secretions into volatile fatty acids and thioalcohols 
that are associated with axillary malodour, [76] while Staphylococcus epidermidis degrades the leucine found 
in sweat to produce isovaleric acid, a major component of foot odour [77].  
There is a rapidly growing interest in the investigation of VOC profiles from different skin commensal 
bacterial species [75] [78]. This research is being driven by a number of motivations including understanding 
the bacterial transformation of skin secretions into odiferous VOCs [76] [79] [80] and uncovering the role of 
bacterial VOCs in interactions with other organisms [81][82][83] as well as bacteria-bacteria interactions [78]. 
Moreover, there is a focus on the potential use of VOCs from pathogenic bacteria as diagnostic tools for 
investigating microbial infections [84]. The detection of microbial VOCs has long been used as a means of 
identifying bacterial species [85] and it is anticipated that this approach could permit non-invasive investigation 
of skin microbial communities in situ [84]. Emerging research around mVOCs in cutaneous health and disease 
will be discussed herein with a focus on their potential as non-invasive diagnostic tools for microbial associated 
cutaneous disease.  
 
2.3.1 Investigating volatile profiles in different skin commensal bacterial species  
The local skin microbiota plays an important role in supporting the skin’s function as a protective barrier 
against pathogen colonization. Microbes can engage in competitive interactions to eliminate pathogens by 
controlling access to space and nutrients through surface occupation and by secreting various metabolites. For 
example, the skin commensal Staphylococcus epidermidis engages in competitive interactions by secreting 
epidermin, a lantibiotic that acts against a broad spectrum of Gram-positive bacteria [72]. Microbes secrete 
volatile metabolites that can also function as signaling molecules, both within microbial communities, and 
between microbes and other organisms. [86] For example, VOCs released by the skin commensal 
Staphylococcus epidermidis have been found to be attractive to female malaria mosquitoes [83]. The role of 
VOCs released by different skin commensal bacterial species in bacteria-bacteria interactions is less well 
understood. Consideration must be given to the potential network of VOC-mediated interspecies 
communication that can influence and modulate the local microbiota, and in turn, affect cutaneous health. In 
this regard, Lemfack and co-workers investigated the volatile profiles of the 2 dominant families of skin 
microbiota, namely Staphylococcaceae and Corynebacteriaceae [78]. VOCs were collected in cell cultures using 
an adsorbent trap with subsequent solvent extraction and analysis by GC-MS. Principle component analysis 
distinguished the 2 bacterial families on the basis of their VOC profiles. 11 compounds were identified from 
Corynebacterium, including 2-nonanone, 2-phenylethanol, 2-undecanone and 2-pentadecanone, and >50 VOCs 
were identified from Staphylococcus strains, wherein ketones were predominant. One strain of Staphylococcus 
(S. schleiferi) was found to produce unique volatile profiles, with 2 newly identified substances (3-(2-
phenylethylamino)butan-2-one and (E)-3-(2-phenylethylimino)butan-2-one) released in large quantities by one 
isolate of S. schleiferi (DSMZ4807). Co-culture experiments revealed that VOCs produced by the DSMZ4807 
isolate selectively inhibited the growth of Gram-positive bacteria and influenced specific phenotypes 
(prodigiosin synthesis, bioluminescence) in Gram-negative bacteria [78]. This research highlights the potential 
role mVOCs play in bacteria-bacteria interactions among skin commensals and suggests that mVOCs might 
contribute to shaping the composition and diversity of the skin microbiota.  
In addition to having distinct physiological effects on cohabiting or competing microbes, mVOCs are also 
known to affect the physiology of their hosts [75]. For instance, a high proportion of Propionibacterium 
typically colonizes sebaceous regions of skin where it hydrolyses the triglycerides in sebum to release beneficial 
fatty acids on the skin. These fatty acids act on the skin by acidifying and emolliating the local environment 
[65],[87]. On the other hand, evidence for the potential role mVOCs might play in disease processes in humans 
is beginning to emerge. Many mVOCs are considered as virulence factors, and they can have a variety of 
different actions on mammalian cells, including inflammatory and cytotoxic effects [88]. For instance, the 
production of short chain fatty acids (SCFAs) by the human gut microbiota can influence the physiology of the 
colon [89], and contribute to the development and progression of diseases like ulcerative colitis [90] and asthma 
[91]. Numerous VOCs produced by the metabolism of skin microorganisms are bioactive compounds, including 
SCFAs and many volatile amines (especially tryptamine and histamine) that can act as inflammatory mediators 
[92]. Further research is needed to understand the impact mVOCs might have on skin physiology, as well as the 
potential network of VOC-mediated interspecies communication and its influence on the local microbiota and 
host physiology. Skin microbial communities are highly sensitive to their underlying environment and its 
changing conditions, and their rapid response to a perturbation provides a sensitive readout of the environment 
within which they reside [93]. It is expected that differences in microbial metabolic processes would be reflected 
in volatile profiles, thus investigation of skin microbial communities via mVOCs could enlighten our 
understanding of their role in cutaneous health and disease, and potentially enable the manipulation of human 
skin microbiota through development of targeted pro-biotics [93]. 
  
2.3.2 Microbial volatiles as diagnostic tools for non-invasive detection of cutaneous wound infections  
Microbial volatiles are considered promising as non-invasive diagnostic tools for earlier detection and 
treatment of microbial infections [94]. For centuries, the characteristic odour produced by Clostridium 
perfringens has been used in recognizing gas gangrene, a severe skin and soft tissue infection [95]. Clinical 
diagnosis of infections via analysis of mVOCs is currently used to diagnose pulmonary [96] and Helicobacter 
pylori infections [97]. Early identification of mVOCs in wound infections could offer a non-invasive, painless 
and reproducible diagnostic approach that could enable earlier detection of infection before the onset of 
malodour, chronicity or necrosis. Current wound infection diagnosis involves surface swabbing, wound exudate 
culture, wound tissue biopsy and the clinician’s judgement of the signs of infection (erythema, oedema, warmth 
and purulence). Additional criteria used to judge signs of infection include discoloration, granulation and wound 
malodour (i.e. mVOCs). Current diagnostic approaches raise concerns over trauma, reproducibility and 
subjective observations [98] [99] and the signs of infection may not be apparent until an infection is well-
established. This has motivated a growing research effort around the analysis of mVOCs for non-invasive 
diagnosis and management of cutaneous wound infections.  
Complementary studies on skin VOCs from different sources (tissue and culture studies as well as in vivo 
research) will assist in validating the origin of candidate volatile compounds and their potential association with 
cutaneous health or disease. Recent evidence for the emission of unique VOC profiles during bacterial biofilm 
formation in human ex vivo cutaneous wound models has emerged (Table 1) [100]. Headspace samples were 
collected from biofilms of methicillin sensitive Staphylococcus aureus (MSSA), Pseudomonas aeruginosa (PA) 
and Streptococcus pyogenes (SP) grown in in vitro and ex vivo cutaneous wound organ culture models. The 
presence and abundance of specific VOCs was influenced by bacterial species, biofilm growth phase and wound 
model. For example, pentanal and 3-methylbutanal were uniquely identified in the early biofilm phases of 
MSSA in all wound models. One alkene (1-undecene) was present in both PA and SP biofilms in all wound 
models at all time points, while several other VOCs were uniquely identified in SP and PA biofilms respectively 
(Table 1). There were 2 VOCs (2-methyl-1-propanol and 3-methyl-1-butanol) common to all 3 bacteria, but 
differences in their relative abundance permitted differentiation between bacterial species [100]. These early 
results highlight the potential utility of VOCs in assessing biofilm development. 
A number of non-invasive approaches for in vivo sampling and analysis of VOC profiles in the headspace 
of cutaneous wounds have emerged. Thomas et al. reported a non-invasive method for in vivo VOC sampling 
in chronic leg wounds [20]. Polydimethylsiloxane membranes were used to collect samples from 5 patients 
(from the wound, a control region of healthy skin, and a boundary region between the two) and analysed by gas 
chromatography ion trap mass spectrometry. They reported VOC profile differentiation between the control and 
lesion areas and between the control and boundary areas (p<0.05) as outlined in Table 1, but not between the 
lesion and boundary areas. Sensor arrays have developed as a portable approach to wound monitoring, and can 
differentiate between uninfected and infected venous leg wounds based on isolated beta-hemolytic streptococci 
[101]. An e-nose system comprising of metal oxide sensors with a SPME desorption unit for sample introduction 
was reported for monitoring burn patients via VOCs. The system distinguished between infected and uninfected 
burns based on samples obtained by SPME pre-concentration of VOCs from swabs and wound dressing material 
[102]. A commercial e-nose (Cyranose320) employing various classifiers (including linear discriminant 
analysis) demonstrated the capability to differentiate between single and poly-microbial species associated with 
diabetic foot infection under different agar culture conditions in vitro [103]. Further development of in vivo 
sampling approaches and identification of candidate biomarkers coupled with continued optimization and 
miniaturization of instrumentation may open up the possibility of point-of-care wound monitoring. It will be 
important to overcome the issue of the diversity of VOCs emitted by skin, commensal microbes and wounds 
that are unrelated to the pathogenic microbial communities present, in addition to the diversity within the 
pathogenic microbial communities, reinforcing the need for translational research in furthering the volatilomics 
field. Microbiome diagnostics via mVOCs may find application in personalized medicine for non-invasive 
diagnosis and management of cutaneous infection and dermatological disorders. 
 
3.  Conclusion 
Studying the biochemical processes in the skin involving VOCs is a promising frontier for non-invasive research 
on skin physiology. It is a versatile approach enabling complementary investigations in tissue, cell culture and 
human participants. Successful deployment of sensor technologies for detection and classification of skin 
volatiles could be highly beneficial for human healthcare [104] and may enable personalized management of 
cutaneous health and disease in the future. However, there are still a number of analytical challenges to be 
overcome in the determination of skin volatiles in order to enable better comparability of results between 
laboratories and to inform the development of skin VOC-based diagnostics and sensor technologies. The 
chemical profile of skin volatiles varies depending on the sampling method used due to selective adsorption of 
analytes on different sampling materials. Furthermore, identification of volatile metabolites from skin is often 
solely reliant on comparing the mass spectrum of an unknown to the reference spectra in a commercial MS 
library. A move towards standardized methodology for sample collection and analysis would improve 
comparability between results generated in different laboratories. Investigation and optimisation of SPME 
adsorption, storage and desorption parameters will ensure a sensitive and reproducible method for skin VOC 
pre-concentration. Careful selection of experimental materials to reduce sample contamination (e.g. glass or 
inert polymers such as Teflon) should be considered. Isolation of the HS atmosphere (e.g. using a wearable 
sampler in vivo [23] or headspace vials in vitro [75]) could further reduce the incidence of environmental 
contaminants. GC-MS compound identification should be supported by independent data through retention 
index matching or reference standards [105] to reduce mistakes in VOC identification and reporting. There will 
be a need for VOC libraries specific to skin to permit rapid identification of compounds in a patient’s sample 
[20]. This will likely be supported by investigations into the production of volatile metabolites at the cellular 
[49] and microbial [106] levels. Meeting these needs will support development of tailored recognition elements 
within sensor arrays for maximum selectivity and sensitivity based on pre-evaluated volatile profiles. Rapid 
advancements in sensing platforms are paving the way for a new class of wearable technology [107] with 
applications in cutaneous health emerging including wearables for wound monitoring [108], and epidermal 
sensors for skin hydration [109] and detection of sub-cutaneous inflammation [110]. This new class of wearable 
technology is already showing promise for targeted VOC sensing on skin [111] and has significance for a variety 
of application areas including clinical diagnostics, management of therapies, and fundamental cell biology and 
skin physiology research.  
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Table 1. Summary of emerging volatile markers associated with cutaneous disease  
Disease/ disorder 
 
n1 Sampling Method 
Analytical 
Method 
Comments Volatile compounds2 p- value 
Compressed 
tissue (pressure 
ulcers) [22] 
 
18 Cotton patch, HS-SPME; 15 hr extraction 
GC-MS, E-
nose 
No definitive markers identified, rather 
different patterns of emission in healthy vs 
compressed tissue 
1,2,3-Propanetriol triacetate^ 
Tritetracontane^  
 
<0.1 
Acute barrier 
disruption (atopic 
dermatitis) [23] 
 
 
 
7 HS-SPME of skin; 15 min extraction  GC-MS 
 
 
Differential volatile emissions before/after 
impairment. Compound identities confirmed 
through RI matching 
 
 
Glycine^  
Squalane*  
Octanal*  
Squalene* 
Nonanal* 
 
 
0.0002 
0.002 
0.05 
0.05 
0.08 
       
Melanoma [21] 
 
2-40 Gauze pad, HS-SPME; 
15 hr extraction 
GC-MS, E-
nose 
Subtle differences in GC-MS data for 2 
participants, but compound identities not 
reported. E-nose melanoma prediction 
correct in 70% of cases. 
 
Propanal 
 
 
Melanoma [60] 
 
 
8 HS-SPME of tissue biopsies; 1 hr extraction GC-MS 
 
Differential expression of volatiles observed 
in melanoma vs matching skin control. 3 
candidate biomarkers in frozen melanoma 
samples proposed.  
 
4-methyl decane^ 
Undecane^ 
Dodecane^ 
 
 
<0.0001 
<0.0001 
0.0006 
Melanoma [62] 
 
 
10 HS-SPME of tissue 
biopsies; 1 hr extraction GC-MS 
 
6 significant features were identified for 
melanoma vs matching skin control. 
Confirmed through RI matching & 
standards. 
 
Dodecanoic acid^ 
Hexadecanoic acid^ 
Tetradecanoic acid^ 
1-Eicosene^ 
2-Ethylhexyl-4-methoxycinnamate^ 
Toluene* 
 
0.05 
Melanoma cells 
[52]  
 HS-SPME of cell 
culture, media & GC-MS 
Quantitative comparison of 31 compounds 
showed significant differences between cell 
lines (melanoma & normal melanocytes).  
 
Dimethyl disulfide$ 
Dimethyl trisulfide$ 
 
<0.006 
supernatant; 30 min 
extraction 
Dimethylsulfone^ 
       
Chronic arterial 
leg ulcers [20] 
 
5 Polydimethylsiloxane 
membrane; 30 min 
extraction  
Thermal 
desorption 
GC-MS 
 
Differentiation between wound & lesion 
areas 
1-(1-Methyethoxy)-2-propanol 
Dimethyl disulfide 
3-Carene 
3,5-Bis(1,1-dimethylethyl) phenol 
 
<0.05 
Biofilms in ex 
vivo wound 
models [100] 
 
1 mL headspace samples 
collected in syringe GC-MS 
 
 
Volatiles specific to bacterial species, as 
well as biofilm and model-specific volatiles 
were observed  
Pentanalm 
3-Methylbutanalm 
Hydrogen cyanidep 
5-Methyl-2-hexanaminep 
5-Methyl-2-heptanaminep 
2-Nonanonep 
2-Undecanonep 
Ethanols 
2-Butanols 
<0.05 
1 Number of participants for in vivo studies; 2 Compounds in bold had their identification supported by retention index matching or analysis of reference standards. 
Those compounds deemed to be from exogenous sources [52] were excluded; ^ Up-regulation of a compound in disease state; * Down-regulation of a compound 
in disease state. $ Compound only present in disease state; m compound unique to methicillin sensitive Staphylococcus aureus; p Compound unique to 
Pseudomonas aeruginosa; s Compound unique to Streptococcus pyogenes 
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